We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Microplate Colorimeter a Cost Efficient Alternative to Fluorescent Detection

By LabMedica International staff writers
Posted on 03 Apr 2012
A new microplate reader suitable for all kinds of multiplex assays has recently been released for the European and American markets.

The Scienion AG (Dortmund, Germany) sciREADER CL has been optimized for colorimetric assays carried out in 96-well microplates. More...
The instrument is capable of detection of multiplex arrays with high sensitivity. It is compatible with various assay-staining technologies, which makes it a cost efficient alternative to fluorescent detection.

The instrument comes with an integrated software package that enables fast set-up time in less than 15 minutes and permits analysis of both single arrays and array batches. The program enables barcode identification of plates, customization of array analysis and reporting, and adaptation of the instrument for sample carriers other than microtiter plates. The software directs automated spot finding and automatic detection of “inArrayDotCode” within each well.

Use of the sciREADER CL is recommended by the manufacturer for DNA and protein multiparameter analysis, genotyping and pathogen identification, clinical diagnostics, autoimmune diseases, infectious diseases, immunology, oncology, food (e.g., allergens) and plant analytics, and drug development.

Holger Eickhoff, CEO of Scienion AG, said, “We are continuously striving to meet the needs of our customers, and adding the new sciREADER to our product portfolio is another module reflecting our strategy to offer total solutions for multiplexing. Fast set-up time and read-out, high resolution digital imaging, and efficient data analysis make our sciREADER the ideal instrument for people in life science research, especially in molecular diagnostics.”

Related Links:

Scienion AG



Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Manual Pipetting Aid
Pipette Controllers macro
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.